Sep 7, 2025, 13:37
Unfractionated Heparin Dosing in ECMO: A Systematic Review and Meta-Analysis
RPTH Journal shared on LinkedIn:
”ECMO is life-saving technology!
What is better for patient outcomes? This review compares low dose vs standard unfractionated heparin on patient morbidity and mortality.”
Read the full article here.
Article: Mortality and Complications in Low-Dose versus Standard-Dose Unfractionated Heparin Anticoagulation for Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
Authors: Wincy Wing-Sze Ng, Rex Wan-Hin Hui, Ka-Chun Leung, Pauline Yeung Ng, Chun-Wai Ngai, Simon Wai-Ching Sin, Chun-Fung Sin
Stay updated on the latest scientific advances in the field of coagulation with Hemostasis Today.
-
Sep 24, 2026, 14:45Bruce Holland: Ex Vivo Assessment of ActiGraft Clot Formation Under Anticoagulation
-
Sep 24, 2026, 14:33Mohamed El Belghiti Alaoui: Thrombin as a Therapeutic Target in Coagulation
-
Sep 24, 2026, 14:22Integrating Thrombosis Risk Into Menopause Care – World Thrombosis Day
-
Sep 24, 2026, 13:41Mahmoud Samir Bayomi: Raise ITP Awareness and Improve Patient Care
-
Sep 24, 2026, 12:56Maria Helena Parrinello: A New Score for Chronic GvHD Risk Assessment at the SIE Congress
-
Sep 24, 2026, 12:44Shehab Mohamed: TP53 Mutations and Outcomes in Myeloproliferative Neoplasms
-
Sep 24, 2026, 12:34Francesca Palandri: Is There Still a Place for Splenectomy in ITP in the Modern Era?
-
Sep 24, 2026, 12:15Cedric Hermans: RPTH Illustrated Review on Von Willebrand Disease
-
Sep 24, 2026, 11:48Factor XII Inhibition and the Future of Contact Pathway Targeting